☆ 4.4 Editorial Material

Special FX: Harnessing the Farnesoid-X-Receptor to Control Bile Acid Synthesis

DIGESTIVE DISEASES AND SCIENCES (2021)

Related references

Note: Only part of the references are listed.

Article Gastroenterology & Hepatology

Bile Acid Synthesis Disorders in Japan: Long-Term Outcome and Chenodeoxycholic Acid Treatment

Akihiko Kimura et al.

Summary: This study followed 7 Japanese patients with bile acid synthesis disorders (BASD) over a 21-year period, finding that chenodeoxycholic acid (CDCA) treatment is effective for 3 beta-HSD deficiency and 5 beta-reductase deficiency, leading to good prognosis through early diagnosis and long-term treatment.

DIGESTIVE DISEASES AND SCIENCES (2021)

Add to Collection

Article Genetics & Heredity

Cholic acid for primary bile acid synthesis defects: a life-saving therapy allowing a favorable outcome in adulthood

Emmanuel Gonzales et al.

ORPHANET JOURNAL OF RARE DISEASES (2018)

Add to Collection

Article Endocrinology & Metabolism

Distinguishing primary from secondary Δ4-3-oxosteroid 5β-reductase (SRD5B1, AKR1D1) deficiency by urinary steroid analysis

Tadahiro Yanagi et al.

CLINICAL ENDOCRINOLOGY (2015)

Add to Collection

Article Physiology

Bile Acid Metabolism and Signaling

John Y. L. Chiang

COMPREHENSIVE PHYSIOLOGY (2013)

Add to Collection

Article Endocrinology & Metabolism

Disorders of bile acid synthesis

Peter Theodore Clayton

JOURNAL OF INHERITED METABOLIC DISEASE (2011)

Add to Collection

Article Cell Biology

Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis

T Inagaki et al.

CELL METABOLISM (2005)

Add to Collection

© Peeref 2019-2024. All rights reserved.